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INTRODUCTION 
Mycoplasma gallisepticum (MG) causes infectious sinusitis in turkeys (86). This 
pathogen was previously referred to as S-6 or pleuropneumonia-like organism (PPLO) (94). 
Like all mycoplasmas, MG is a specialized bacteria that lacks a cell wall and it survives only 
1-3 days in feces at 68° F. MG attaches to the tracheal epithelium of poultry (122) and once 
a turkey is infected, that bird is considered to be infected for life. MG is transmitted from 
breeder hens to turkey poults through the egg (1, 65). The National Poultry Improvement 
Plan requires that turkey breeder flocks be tested for MG and must be negative before eggs 
can be hatched and sold to producers (97). Infected flocks of breeding birds must be 
depopulated. Consequently, all infected breeder flocks must be sent to slaughter. 
Pathogenicity varies widely between isolates and turkeys are more susceptible to MG 
infection than chickens (70, 132). Infectious sinusitis has an incubation period that lasts from 
6 to 10 days and the duration of clinical signs may range from weeks to months (132). MG 
infection typically causes an increase in mucus production at all levels of the turkey 
respiratory tract. Accumulation of mucus production is most obvious in the infraorbital 
sinuses which become markedly swollen. Mortality is less than 2% in uncomplicated cases 
but may be significantly elevated with concurrent bacterial or viral infections which 
contribute to elevated mortality, increased condemnations at processing, and reduced growth 
rate (72). Unfortunately, concurrent infections are the rule since each gram of poultry dust 
contains up to 800,000 E. coli and 10 to 15 percent of intestinal E. coli are pathogenic (60). 
Mycoplasma gallisepticum (MG) continues to be a problem for the commercial turkey 
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industry in the United States. Commercial turkey producers lose money due to cost of 
medication, elevated mortality, reduced growth rate in affected flocks, and the necessity of 
sending all infected breeder flocks to slaughter. Condemnation of turkeys at the processing 
plant is a major cause of economic loss. Mucoid lesions in the air sacs can not be removed 
by suction devices at the processing plant resulting in condemnation of the entire carcass. In 
1992, approximately 30-40% of carcasses from MG-infected commercial turkey flocks in 
Michigan were condemned (personal communication, BilMar Turkey Company). 
Confirming a diagnosis of MG infection may be difficult and time-consuming in 
laboratories that do not routinely work with avian mycoplasmas. Faster identification of 
positive cases would reduce the opportunity for the organism to spread to other farms. A 
definitive diagnosis is based on the isolation and identification of the causative organism but 
isolation requires special media and may take weeks. Serology is useful but is not without 
problems. Serological tests include the serum plate agglutination test which is capable of 
detecting IgM antibody early in the course of infection and the hemagglutination inhibition 
(HI) test which detects IgG antibody (58). The National Poultry Improvement Plan (97) has 
ruled that HI titers of ~ 1 :40 are suspicious and flocks must be monitored whereas HI titers of 
1 ~ :80 are positive and the flock is presumed to be infected. Unfortunately, titers are often 
equivocal. In recent years, an ELISA test has become available but false positive results have 
been encountered in flocks that have previously been vaccinated with oil-adjuvanted 
vaccines. The serum plate agglutination test (SP A) and the enzyme linked immunosorbent 
assay (ELISA) test are sensitive but may yield false positive results (11). The polymerase 
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chain reaction (PCR) has the advantage of speed, sensitivity, and specificity. However, this 
technique is available only in few specialized laboratories, is expensive, and there is a danger 
of false positives due to contamination by environmental laboratory strains (84). 
The avidin-biotin immunohistochemical technique has the potential to provide a rapid 
confirmation of Mycoplasma gallisepticum in turkeys with swollen infraorbital sinuses. With 
this procedure, primary antibodies directed against MG antigens are produced in laboratory 
animals, such as rabbits. An antigen-containing specimen is embedded in paraffin, sectioned, 
and displayed on a microscope slide. Primary antibodies are applied to the slide and, after 
rinsing the slide, are followed by biotinylated secondary antibodies produced in a different 
species of laboratory animal, such as a goat. If primary antibody attaches to the MG 
antigens, biotinylated secondary antibodies will attach to the primary antibodies. Incubation 
with chromogen results in a chemical reaction with peroxidase attached to the secondary 
antibodies and deposition of a red deposit. A vidin-biotin immunohistochemical tests are 
inexpensive, can be completed in hours, and are readily performed in most diagnostic 
laboratories. The immunoperoxidase technique can be run on tissues routinely fixed in 10% 
neutral buffered formalin . An immunoperoxidase procedure has been developed in rodents 
which allows visualization of individual mycoplasma organisms ( 62). 
The purpose of this research was to develop an avidin-biotin histochemical test to 
detect M gallisepticum infections in turkeys. This procedure should make it possible to 
confirm or deny the presence of MG in turkeys with swollen heads within 48 hours after 
specimens are submitted to a diagnostic laboratory. The avidin-biotin test must be 
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sufficiently sensitive to detect MG antigens in turkey respiratory tissues and it must be 
specific. The test must not cross-react with respiratory tissues from mycoplasma-free 
turkeys, turkeys infected with Mycoplasma meleagridis, or turkeys infected with 
Mycoplasma synoviae. The procedure should be cost-effective and amenable for routine use 
in a diagnostic laboratory. 
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REVIEW OF LITERATURE 
This literature review includes three parts: characteristics of Mycoplasma 
gallisepticum organisms, immunohistochemistry techniques used in this research, and a 
review of the disease in turkeys caused by M gallisepticum infection. 
Mycoplasma gallisepticum. The earliest reports of infectious sinusitis in turkeys 
came from England. In 1905, Dodd described a disease that he called "epizootic 
pneumoenteritis of the turkey" and Gram-Smith reported "swollen head" in turkeys two years 
later (41, 81). Markham and Wong in 1952 discovered that infectious sinusitis of turkeys and 
chronic respiratory disease of chickens were caused by the same pleuropneumonia-like 
organisms (PPLO) (94). In 1960, Edward and Kanarek proposed the name Mycoplasma 
gallisepticum (MG) for these PPLO of poultry (45). Different strains of MG exist and the 
most strains used in research include S6, R, and F. The S6 strain of MG is the prototype 
strain which was originally isolated from the brain of turkeys with infectious sinusitis (135). 
F strain is a low virulence vaccine strain that originated from studies by van der Heide 
employing the Connecticut F strain (132). The pathogenic R strain was isolated in 1963 from 
a chicken with airsacculitis by Dale Richy at the University of Georgia Poultry Disease 
Research Center and is frequently used as a challenge strain in research (132). 
Ultrastructural Morphology and Replication. In dense aggregates, M gallisepticum 
have a cocco-bacilliform shape and are approximately 0.25-0.5 µmin diameter (4, 132). 
When separated, MG have an irregular, elongated shape (3). M gallisepticum is a 
specialized bacteria with a lipoprotein cell membrane measuring about 80-100 A thick but 
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does not possess a cell wall (101). The lipoprotein cell membrane enables mycoplasma to 
adapt their shape according to the host cell surface contours (102). MG are capable of slow 
gliding movement which is facilitated by a tiplike terminal bleb which points in the direction 
of movement and adheres to solid surfaces (3, 27, 88). An infrableb region is composed of 
granular material (88). A system of submembrane tubules represented by smoothly curved 
loops is present in M gallisepticum which may serve as a cytoskeleton. It has been 
postulated that submembrane tubules may reversibly anchor to surface proteins which 
enables a 'caterpillar' type of motility (78). Tubules have a diameter of 40 nm, a central core 
of 10 nm, and both ends of each tubule is anchored in the infrableb region (78). Replication 
of MG occurs by binary fission that begins with formation of a second bleb opposite the 
original bleb and by budding ( 44, 89). 
Mycoplasma gallisepticum attaches to tracheal epithelium of poultry by a 
combination of hydrophobic and ionic bonds (22, 102). Host cell membrane receptors for 
attachment ofMG's terminal bleb consist of the sialic acid moieties of sialoglycoproteins or 
sialoglycolipids (103). Terminal sialic acid residues have been identified on the apical 
surface of epithelial cells and endothelial cells in the trachea and lung of healthy turkeys (5). 
Glycophorin, the erythrocyte membrane glycoprotein carrying almost all sialic acid moieties 
of erythrocytes, is the major receptor for M gallisepticum (15). Binding of MG to 
erythrocyte membranes results in hemagglutination (118). Banai has shown that adherence 
of MG to erythrocytes is not dependent upon ionic gradients across the mycoplasma cell 
membrane (16). 
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Colony Morphology and Growth Requirements. M gallisepticum colonies are 
usually no more than 0.2-0.3 mm in diameter and appear as tiny, smooth, circular, translucent 
masses with a dense, raised central area (132). Adjacent colonies frequently coalesce. 
Mycoplasma gallisepticum requires an enriched medium with 10-15% heat-inactivated swine, 
avian, or horse serum for optimum growth at pH 7.8 and 37-38° C. Colonies on agar media 
require a moist atmosphere and incubation for 2-5 days (132). Frey's media will support the 
growth of M gallisepticum, M synoviae, M meleagridis, and many other avian 
mycoplasmas (53). 
Biochemical properties. Mycoplasma gallisepticum has neuraminidase-like enzyme 
activity that is absent in other avian mycoplasmas (104, 112). MG ferments glucose and 
maltose resulting in production of acid but not gas. It does not ferment lactose, dulcitol or 
salicin. It is phosphatase negative and will agglutinate turkey and chicken erythrocytes (132). 
MG requires an exogenous source of cholesterol for its growth because it lacks the ability to 
synthesize cholesterol. During the growth period, cholesterol is first incorporated into the 
outer half of the MG lipid bilayer and subsequently moves from the outer surface of the 
membrane to the inner surface (108). Metabolic activity is probably required for motility and 
formation of the terminal bleb attachment structure (42). 
Genetics. M gallisepticum has a DNA genome. Studies with ribosomal RNA gene 
probes indicate that there is genotypic heterogeneity between different MG strains (133). 
Recently, Tigges reported that the total genome size of the R strain of MG is 998kb (121). A 
family of genes encoding for the adhesin of M gallisepticum, pMGA, have been identified. 
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Variability in pMGA structure observed in MG may represent a mechanism for evasion of 
the immune response and probably results from expression of one variant pMGA gene from 
the gene family (93). 
Antigens. The plasma membrane of M gallisepticum contains at least 35 acylated 
polypeptides which represent the major antigens and immunogens (67). Palmitic acid is the 
major ester-bound fatty acid and linoleic acid is the major amide bound-linked fatty acid 
(67). Immunogenic integral membrane proteins specific to M gallisepticum which have been 
intensively studied include proteins p64 (64 kDa) and p56 (56 kDa) (12, 115). Protein p64 
was found in 19of19 strains of MG and p56 was detected in 18of19 MG strains. Markham 
has described a 67 kDa membrane protein (pMGA) which is responsible for 
hemagglutination. Avakian's p64 and Markham's pMGA may be identical lipoproteins 
specific to M gallisepticum which function both as an adhesin and as a hemagglutinin (52, 
67, 92). Lipoprotein p64 is located in the cell membrane near the base of the terminal bleb 
(54). In addition, a different surface protein of 155 kDa has been identified in the cell 
membrane at the tip of the terminal bleb organelle which may facilitate attachment (42). 
Surface epitopes of M. gallisepticum may vary among colonies of the same passage, 
between passages of the same strain, and among different strains (55). Furthermore, 
monoclonal antibodies may recognize proteins of different sizes in different isolates (55). 
However, one membrane protein containing a conserved epitope present in most M 
gallisepticum strains has been identified near the attachment organelle (47). This protein has 
a molecular weight of 98 kDa (p98) and has been found only in M gallisepticum ( 4 7). 
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Immunogenicity. Kleven reported that an antibody response to MG can be detected 
by the serum plate agglutination test within a few days after infection (75) and by the 
hemagglutination-inhibition (HI) test two weeks post infection. The first antibody generated 
in response to MG infection is lgM which persists for up to 77 days. The lgM response is 
followed within a week by an lgG response which persists in the serum for months (6). The 
bursa ofFabricius has a vital role in development of the peripheral humoral immune response 
(6). Cellular immunity of the T-cell type against MG has been reported in the nasal cavity 
and the lungs of chicken after intramuscular injection (6). MG strains differ in their ability to 
induce an antibody response measured by hemagglutination-inhibition (HI) or enzyme-linked 
immunosorbent assay (ELISA) tests ( 40). 
Pathogenicity. Pathogenicity varies widely between isolates (82, 83). Jordan 
reported that the severity of MG diseases is influenced by the age of the host, route of entry 
of mycoplasma, the number of infecting organisms, and the virulence of the infecting 
mycoplasma (70). Concurrent bacterial or viral infections associated with MG contribute to 
their pathogenicity (126). 
Mycoplasma preferably colonize respiratory and genital mucosa (56, 123). 
Adsorption or adherence of mycoplasma to a host cell membrane is the initial step in 
infection. The ability to adhere tightly to target cells is essential for colonization and loss of 
adherence in MG has been associated with loss of virulence. M gallisepticum possess 
integral membrane proteins called adhesins which facilitate attachment to host cell receptors 
(103). Receptors on host cell membranes consist of sialic acid moieties, such as N-acetyl 
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neuraminic acid, which are conjugated to glycoproteins or glycolipids (103, 126). 
Prolonged mycoplasma adherence to host cell membranes is required to cause host 
membrane damage (102). However, the mechanism by which Mycoplasma gallisepticum 
injures the host cell is not clearly understood. Some strains of MG (S6) in turkeys have 
been found to possess non-exotoxin neurotoxins that are responsible for encephalitis and 
polyarteritis nodosa in the brain of turkey poults (119, 126). Hydrogen peroxide (126) and 
polysaccharides (56) are also produced by mycoplasma and may contribute to pathogenicity 
by causing membrane and tissue damage. The hemolysin of MG has been shown to be 
hydrogen peroxide which may be a virulence factor (31 ). 
Multiplication of M gallisepticum takes place on the cell surface and both the 
integrity of the host cell membrane and the host cell function may be altered (56). MG will 
inhibit ciliary activity in tracheal organ cultures. However, this cilia-stopping effect (CSE) is 
not affected by either neuraminidase which disrupts cell adherence nor by catalase which 
inactivates hydrogen peroxide (31 ). No change in the activity of dehydrogenase enzymes 
associated with the tricarboxylic acid cycle in respiratory epithelial cells was found in sinuses 
of turkeys experimentally infected with MG (22). 
Immunoperoxidase Histochemistry. Four basic immunoperoxidase cytochemical 
techniques for tissue antigen demonstration have been described (23, 46). These procedures 
are described below. 
1. Direct Method: Horseradish peroxidase is chemically linked to the primary antibody. 
Peroxidase-labeled antibody binds to a specific antigen in tissue and a colored end product 
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precipitates at the antigen site after a chromogen is applied. This technique has the advantage 
of being quick and producing few nonspecific reactions. The primary disadvantage is that a 
separate specific conjugated antibody must be produced to identify each individual, different 
antigen in tissue sections. Due to a lack of sensitivity, frozen sections must be used for 
consistent results. 
2. Indirect Method: Primary unconjugated antibody is applied to tissue on a microscope 
slide and binds to a specific antigen. Subsequently, a peroxidase enzyme-labeled secondary 
antibody attaches to the primary antibody and a substrate is added to localize the reaction. 
Primary antibodies produced in one animal species, such as a rabbit, are excellent antigens 
when injected into a different animal species, such as a goat. This technique is more versatile 
than the direct method because the same conjugated secondary antibody produced in one 
animal species can be used to detect primary antibodies directed against a variety of antigens 
which are produced in a different species of laboratory animal. The indirect method takes 
twice as long as the direct method, has an increased chance of nonspecific reactions, and the 
procedure works best to detect antigen in frozen sections. 
3. Peroxidase-Antiperoxidase Method. This three-layer technique employs primary 
antibodies specific for the antigen, secondary "link" antibodies which bind to the primary 
antibody and to a peroxidase-antiperoxidase (PAP) antibody complex. Primary antibody and 
antiperoxidase antibodies are produced in the same animal species. One Fab site of the link 
antibody binds to the primary antibody and the other Fab site of the link antibody binds to the 
PAP complex. Peroxidase enzyme is seen via a substrate-chromogen reaction. The PAP 
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method is more sensitive that the direct or indirect methods and can be used in formalin-fixed 
sections which makes retrospective studies possible. 
4. Avidin-Biotin Method: This procedure utilizes the phenomenon that avidin of egg-white 
origin binds to 4 molecules of biotin in a nonimmunologic manner. Three reagents are used 
in this procedure: primary antibody directed against a specific antigen, secondary antibody 
conjugated to biotin, and a complex of peroxidase conjugated-biotin and avidin. Free sites 
on the avidin molecule bind to biotin conjugated to the secondary antibody and a red 
precipitate forms following addition of chromogen. This method is relatively sensitive and 
can be used on formalin-fixed specimens. 
Endogenous peroxidase activity. The substrate-chromogen reaction is nonspecific in 
that it can not distinguish between peroxidase enzyme localizing the cellular antigen and pre-
existing tissue peroxidase activity located primarily in erythrocytes and leucocytes. 
Erythrocytes contain pseudoperoxidase and myeloperoxidase is present in granulocytes ( 46). 
Removal of endogenous enzymatic activity at the beginning of the staining procedure is 
necessary to prevent nonspecific reactions ( 23). Endogenous peroxidase can be irreversibly 
denatured by applying 3% hydrogen peroxide directly to the tissue sample. This solution 
does not denature horseradish peroxidase. Other solutions that can be used to prevent this 
endogenous activity include 0.01 % periodic acid followed by sodium borohydride and 0.2% 
acetic acid with 1 % sodium nitroferricyanide. 
Nonspecific background staining. Nonspecific background staining is not due to an 
antigen-antibody reaction ( 23). Nonspecific specimen staining is caused by attachment or 
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adsorption of protein antibodies to highly charged collagen and connective tissue elements in 
tissue. Secondary antibody with conjugated peroxidase nonspecifically attaches to charged 
sites resulting in a positive color reaction. Background staining can be prevented by the 
addition of a protein solution to the tissue specimen prior to applying the primary antibody. 
Nonimmune serum from the same animal species that produced the secondary antibodies will 
fill most of the charged sites and thereby prevent primary antibodies from binding to collagen 
(28). Nonimmune serum is used at a 1 :5 to 1 :20 dilution and allowed to remain for 10 to 20 
minutes on the specimen. Excess nonimmune serum is tapped off leaving a thin layer coating 
the tissue. Other causes of nonspecific staining include: inappropriate antibody dilutions, 
incomplete removal of paraffin, improper rinsing of slides, incorrect substrate incubation, 
and hemolysis of erythrocytes by nonimmune serum. 
Fixation. Tissue sections contain only a finite quantity of antigen and preservation of 
antigen is the primary concern in fixation. Antigen in a tissue section must be fixed to avoid 
diffusion or being washed out of the specimen. Adjacent cells must be fixed so that tissue 
morphology is preserved and a correct interpretation is possible. Overfixation may denature 
the antigen and may produce aldehyde cross-links that prevent primary antibody from 
reaching the antigen. Chemical fixation denaturates and stabilizes protein by coagulation or 
by forming additive compounds (29). Formaldehyde binds to amino groups on side chains of 
amino acids and cross-links proteins which may mask antigenic sites (29). Formaldehyde 
penetrates quickly but fixes slowly because significant time is required to cross-link tissue 
proteins (29). Methyl pentanedial glycol (MPG) forms fewer crosslinks than 10% neutral 
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buffered formalin so that cytoplasmic and membrane antigens are better preserved. In 
addition, MPG is non-toxic, non-corrosive, and non-inflammable (American Histology). 
Exposure of fixed tissues to proteolytic enzymes results in digestion of aldehyde linkages and 
exposes protein antigens. 
Optimal fixation consists of the minimum time and minimum fixative concentration 
that will preserve tissue morphology. The following conditions should be considered when 
preparing specimens for immunohistochemistry (23, 113): 
1. Tissue specimen size should not exceed an area of 2 cm square or 3-4 mm in 
thickness. 
2. At least 15-20 volumes of fixative should be used for every volume of tissue. 
3. Tissue samples should be placed directly into the fixative after being cut so that the 
specimens do not dry out. 
4. Most fixation is done at room temperature (25° C). 
5. Fixation time should be as short as possible to preserve tissue morphology. For 
formalin, 6 to 12 hours is usually adequate but the time required may vary depending 
upon the type and thickness of the tissue. 
6. Different types of fixatives have been found to be useful for immunohistochemistry. 
These include 10% buffered neutral formalin, Bouin's fixative, Zenker's fixative, and 
methyl pentanedial glycol. 
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Mycoplasma gallisepticum Infection of Turkeys (Infectious Sinusitis ). Turkeys 
are more susceptible to M gallisepticum infection than chickens and MG causes a disease of 
turkeys called infectious sinusitis (39, 70, 86, 132). The disease was originally called 
"epizootic pneumoenteritis" by Dodd in 1905 but other names include swell head, 
airsacculitis and PPLO infection. All ages of turkeys are susceptible and poults may show 
signs of infection as early as 3-4 weeks old (63). MG has been re-isolated from the lung, 
trachea, air sacs, brain, kidney, and spleen in turkeys experimentally inoculated via the 
trachea (100). In turkeys, the incubation period before appearance of clinical signs is 6 to 
10 days and infection may persist for weeks or months in untreated flocks (132). Age of the 
host, route of infection, virulence of organisms, and predisposing stress factors, such as 
chilling, overcrowding, or high ammonia levels, can affect the severity of infectious sinusitis 
(70, 116). Mortality is less than 2% in uncomplicated cases but may be significantly 
elevated with concurrent bacterial or viral infections (72). Concurrent infections frequently 
occur since each gram of poultry house dust may contain up to 800,000 E. coli (60). 
Economic losses result from elevated mortality, reduced feed efficiency, medication costs, 
and the necessity to send all infected breeder flocks to slaughter (96, 132). 
Natural and Experimental Hosts. Mycoplasma gallisepticum occurs primarily in 
domestic chickens and turkeys but other host species include pheasants, guineas, peafowl, 
chukker partridge, bobwhite quail, pigeons, Japanese quail, and house finches (132). Geese 
and ducks may become infected with MG (19, 56, 98, 129). In addition, MG has been 
isolated from the respiratory tract of wild turkeys showing clinical signs and lesions typical 
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of infectious sinusitis ( 38, 68). 
Transmission. Transmission may occur by vertical or horizontal mechanisms. 
Because M gallisepticum is transmitted from infected female birds to their offspring through 
the egg (1 , 19, 65, 116), the National Poultry Improvement Plan requires that all participating 
turkey breeder flocks be free of this disease (97). Horizontal transmission can occur by direct 
contact with infected carrier turkeys or chickens or via air-borne dust or droplets (132). 
Contaminated litter, equipment, or people and inadequate rodent control have been 
implicated in outbreaks (69). Mycop/asma gallisepticum numbers peak in the upper 
respiratory tract of chickens 2 weeks after infection, and it is likely that transmission occurs 
most readily during this acute phase of the disease (116). Mycoplasma gallisepticum can 
survive 4 days on feathers and feed, 3 days on human hair, 2 days on cotton and rubber or in 
water, and 24 hours in the human nose (33). 
Clinical Signs. Clinical signs in naturally infected turkeys include shaking of the 
head, coughing, sneezing, snicks, ocular discharge, labored breathing, and moist tracheal 
rales. Mild keratoconjunctivitis with frothy exudate in the eye may be the only sign during 
early stages of the disease (72). Swelling of one or both infraorbital sinuses by a gelatinous 
exudate which becomes caseous after few weeks of infection is a classical clinical sign of 
infectious sinusitis and bulging of severely distended sinuses may interfere with vision (53, 
63, 70, 87). Swollen sinuses is associated with attachment of MG organisms to respiratory 
epithelial cells lining the sinuses by the terminal bleb (21, 109). Mucoid nasal discharge is 
believed to represent an overflow of exudate from affected infraorbital sinuses (59). Some 
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strains of M gallisepticum produce a fatal encephalopathy in turkey that is associated with 
torticollis and opisthotonos (32, 36, 37, 126). Intravenous inoculation of turkeys with MG 
strain S6 usually results in nervous signs and localization within cerebral arteries (35). 
Commercial turkeys with infectious sinusitis experience a reduced rate of growth (87). 
Domesticated and wild turkey breeding hens infected with MG may experience a significant 
drop in fertility, egg production and hatchability (1, 107, 132) 
Macroscopic Pathology. Macroscopic lesions in the respiratory system result from 
mucus accumulation at all levels of the respiratory tract including the nasal passages, sinuses, 
trachea, bronchi, lungs, and air sacs (132). At later stages of infection, inflammatory exudate 
turns purulent, fibrinous, or caseous and caseous exudate may persist indefinitely in 
infraorbital sinuses (59, 87). Salpingitis characterized by caseous plugs has been reported in 
turkey poults experimentally infected with M gallisepticum via the yolk sac ( 43). Fibrinous 
perihepatitis and adhesive pericarditis, probably due to concurrent secondary infections, has 
been reported in turkeys experiencing infectious sinusitis (127). 
Microscopic Pathology. Infected hosts react to mycoplasma infections with 
serofibrinous inflammation and activation of cell-mediated defense systems. Transformation 
ofT-cell lymphoblasts may be initiated by a mutagenic substance resulting in extensive 
proliferation of immature lymphocytes (56). Consequently, lymphoid hyperplasia in 
respiratory tract subepithelial connective tissue is a characteristic lesion associated with 
mycoplasma infections. Histopathology has been observed in the respiratory tract, brain, 
joints, and oviduct of turkeys infected with Mycoplasma gallisepticum. 
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Sinuses and nasal passages of turkeys infected with MG are characterized by mucus 
accumulation, dilation of intraepithelial glands by mucus, hyperplasia and hypertrophy of 
goblet cells, and infiltration of the lamina propria by lymphocytes, reticulocytes, and plasma 
cells during the early stages of disease. Later, hyperplastic lymphofollicular structures with 
germinal centers appear in the submucosa of the sinuses, nasal passages, lungs and air sacs 
which are highly suggestive of infection by M gallisepticum (17, 56, 70, 73). In the lung, 
lymphocyte infiltration in air capillary walls may result in thickened air capillary walls and 
atelectasis of air capillary lumina with consolidation and emphysema in adjacent lobules. 
Arteries in brains of commercial and experimental poults infected with M gallisepticum 
showed endothelial cell swelling and hyperplasia, fibrinoid necrosis of the tunica media, and 
a transmural infiltration of lymphocytes, plasma cells, and macrophages (35, 119). Small 
focal areas of necrosis in the brain were presumed to be due to occlusion of blood vessels 
(32, 36). 
M. gallisepticum has been demonstrated to occur in subsynovial and periarticular vessels 
by immunofluorescence prior to development of clinical signs of arthritis. By 30 days 
postinoculation, turkeys had clinical signs of acute arthritis and MG was cultured from 
synovial fluid. Periarticular arteries had sclerotic changes and lymphoplasmacytic cellular 
infiltrates. Also, hypertrophy of synovial membranes was observed. (34). 
Inoculation of MG into yolk sacs of day-old poults resulted in infiltration of oviduct walls 
with numerous lymphocytes and a few heterophils ( 43). 
Ultrastructural Pathology. Electron microscopy has been used to study the interaction 
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between M gallisepticum and infected cells in the infraorbital sinuses, trachea, and blood 
vessels. 
Colonization of turkey infraorbital sinus epithelial cells by M gallisepticum results in 
loss of cilia and microvilli. Localization of mycoplasma in crypts and among cilia on the 
host cell surface may provide a protection mechanism against phagocytosis (102). In 
transmission electron micrographs, individual MG organisms are located between and within 
the cytoplasm of sinus epithelial cells and appear as large, round, dense bodies surrounded by 
a narrow zone of granular particles (21 ). Degeneration of sinus epithelial cells is limited to 
the distal part of the cell with nuclei and basal areas remaining unaffected (21). Scanning 
electron microscopy of MG-infected sinuses reveals swollen, dome-shaped epithelial cells 
and an absence of necrosis or ulceration (109). 
Tracheal injury following infection by M gallisepticum can be detected by scanning 
electron microscopy and initial changes consist of swelling of individual respiratory 
epithelial cells and edema of the mucosal surface. Edema is followed by accumulation of 
mucus and fibrin which may solidify and partially obstruct the trachea (64). In chicken 
tracheal explants, Mycoplasma gallisepticum organisms were observed in close proximity to 
cilia and microvilli of epithelial cells. Following sloughing of degenerating epithelium, MG 
invaded the basement membrane and attached to collagen fibers in the lamina propria (3). 
A remarkable degree of endothelial swelling without endothelial cell proliferation was 
observed in brains of turkeys intravenously injected with the S6 strain of MG. Endothelial 
cell cytoplasm and nuclei were greatly enlarged resulting in nearly total occlusion of the 
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lumen of capillaries (90). 
Diagnosis. A definitive diagnosis is based upon isolation and identification of the 
causative organism. Five to 10 tracheal cultures from turkeys or chickens are adequate in 
acute infections but 30 to 100 birds should be cultured in chronic cases. Mycoplasma 
gallisepticum can be grown in Frey's media which contains penicillin and thallium acetate to 
inhibit bacterial and mycotic contamination. Phenol red in Frey's media turns from red to 
orange to yellow as acidity increases. Four to 5 days are required for colonies to become 
visible on agar plates incubated at 37 ° C (76). In many laboratories, colonies of MG on agar 
plates are identified by fluorescein-labeled rabbit antibodies directed against MG (76). 
Serological tests available to detect antibodies against M. gallisepticum include serum 
plate agglutination, hemagglutination inhibition, and an enzyme-linked immunosorbent 
assay. The serum plate agglutination (SP A) test can detect an antibody response within a few 
days after infection. The SP A test is more sensitive than the hemagglutination inhibition 
(HI) test and is capable of detecting lgM antibody early in the course of infection (70). 
Absorption of gamma globulins to Mycoplasma gallisepticum during incubation may cause 
nonspecific reactions to MG antigen used in the SPA test (24). Other causes of nonspecific 
agglutination include storing serum at 4° C, freezing and thawing serum, and vaccinating 
birds with oil emulsion vaccines (10, 77). The hemagglutination inhibition test does not 
become positive until two weeks post infection. The HI test is more specific than the SP A 
test and detects IgG antibody (58, 70). The National Poultry Improvement Plan has 
determined that HI titers less than or equal to 1 :40 represent suspicious flocks which must be 
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monitored and HI titters of 1 :80 or greater are positive and indicate an infected flock (97). In 
wild turkeys, antibodies against M gallisepticum could be detected by SP A for one year after 
infection while HI titers declined after three months (106). In recent years, the enzyrne-
linked irnrnunosorbent assay (ELISA) test has become available but false positive results 
have been encountered in flocks previously vaccinated with oil-adjuvanted vaccines (10, 11, 
77). The sensitivity of ELISA, HI, and SP A are affected by the antigen strain used in the test 
(11). 
Additional diagnostic tests for M gallisepticum have been developed. DNA probes have 
been used to detect MG but the sensitivity of DNA probes is limited to detection a large 
number of organisms (106) which are found only during the acute phase of infection (96). 
Polymerase chain reaction (PCR) tests are much more sensitive and can detect 1 o-6 pico grams 
of MG DNA which is less than the total chromosomal content of one MG organism (96). 
Although PCR is highly sensitive and specific, there is always a danger of false positive 
reaction from environmental contamination (84). A radioirnrnunoassay has been used 
experimentally in chickens to detect MG antibodies in serum, yolk fluids, and tracheal 
washings (74). Flow cytometry to identify MG has been described which requires specific 
antibodies labeled with fluorescein isothiocyanate (95). 
Treatment. Treatment of infectious sinusitis will frequently alleviate signs but will not 
eliminate MG from infected turkeys. Antibacterials that have been successfully used to treat 
this disease include tylosin, chlortetracycline, oxytetracycline, erythromycin, spectinomycin, 
lincomycin, and streptomycin (72, 85, 132). Fluoroquinolones, including enrofloxacin and 
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danofloxacin, have been found to be effective against MG (71, 72). Antibiotics may be 
administered by water, feed, or subcutaneous injection (132). Some strains of MG have 
developed resistance to commonly used antibiotics. 
Prevention. A series of rigid biosecurity measures are essential to prevent horizontal 
transmission. Flock caretakers and servicemen need to wear clean clothes and footwear 
when moving between flocks. Employees in contact with commercial turkeys should not 
own game birds or chickens. Contaminated litter should be hauled in covered trucks to avoid 
airborne transmission. Loading chutes and other equipment must be thoroughly cleaned 
before being moved from farm to farm. Livehaul trucks need to be cleaned and covered with 
netting to avoid dropping feathers and other debris from infected birds along the roads. 
Predators should not have access to dead carcasses. Rodent control is necessary to prevent 
rodents from moving from MG-infected houses onto neighboring premises (69). 
Dipping turkey eggs in antibiotic solutions, injecting antibiotic directly into eggs, and 
heating turkey eggs have been used to reduce the incidence of vertical transmission. Egg 
treatments do not completely eliminate M gallisepticum from turkey poults and are seldom 
used today. Dipping warm eggs in tylosin or erythromycin for 30 minutes proved to be of 
value. A temperature differential of 37° C between the eggs and a solution containing 800 
ppm erythromycin yields the highest levels of antibiotic within the eggs (8). Inoculation of 
lincomycin-spectinomycin into the albumen ensures that a known volume of antibiotic enters 
the egg (72). Heating infected hatching eggs to 114° F within 12 hours will inactivate M 
gallisepticum but hatchability will be reduced 8-12% (131 ). 
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Immunization. Mechanisms of acquired immunity against M gallisepticum in poultry is 
not completely understood (124). Cell mediated immunity does not protect chickens from 
infection or development of air sac lesions following exposure to MG (79, 102). Barker 
reported that a complement-like substance may play a role in inactivation of MG by the 
immune system in laboratory animals (18). Resistance of chickens immunized against M 
gallisepticum is mediated by bursal dependent lymphoid cells (80). Protection does not 
correlate with circulating antibody titers (117), but local immunoglobulin titers do correlate 
positively with immunity in chickens (128). Chickens infected with M gallisepticum 
produce IgA, IgM, and lgG on mucosa! surfaces of the respiratory tract (14, 128). 
Development of secretory antibodies in chicken tracheas is associated with a sharp decline in 
numbers of M gallisepticum colonizing the trachea and a decline in tracheal lesions (128). 
Secretory immunoglobulins inhibit attachment of MG to chick tracheal rings in an organ 
culture system and protect against ciliostasis in a dose-dependent manner (14). Protection of 
chickens following immunization may be due to immunoglobulins on mucosal surfaces 
which prevent attachment of M. gal/isepticum to epithelial cells on mucosa! surfaces (80). 
Vaccines consist of live M gallisepticum with reduced virulence or killed organisms in 
bacterins (7). In most instances, the ability of M gallisepticum to induce acquired immunity 
is directly proportional to its ability to cause disease (125). F strain is a naturally occurring 
isolate of MG that is commercially available for vaccinating chickens and displaces virulent 
field strains of MG in vaccinated layer flocks (57, 72). Unfortunately, F strain vaccine has 
been shown to reduce egg production by more than 5% in white leghorn chickens (26). F 
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strain has low transmissibility and transmission between birds diminishes with time (57). 
Also, F strain is fully virulent for turkeys and has been transported from vaccinated chicken 
flocks to turkeys resulting in severe disease (49, 57, 86). 
The 6/85 vaccine strain of M gallisepticum induces significant protection against air sac 
lesions when administered to chickens via aerosol at 2 weeks of age ( 49). Chickens 
vaccinated with this product exhibit significantly lower egg production loss than 
nonvaccinated control birds (50). Fortunately, the 6/85 strain has minimal virulence for 
chickens and turkeys ( 49). The 6/85 strain is genetically stable after passage in chickens and 
turkeys as indicated by consistent DNA fragmentation caused by several endonucleases and 
consistent protein patterns following sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (51 ). 
A temperature sensitive vaccine strain has been created by exposing a culture of M 
gallisepticum to a chemical mutagen, nitrosoguanidine, and selecting a clone capable of 
growing at cooler temperatures found in the trachea (125). This live clone, called ts-11 , has 
retained the ability to colonize the trachea of chickens and can stimulate a protective immune 
response (125). Temperature sensitive mutants grow 100 times more efficiently at the 
permissive temperature (33° C) than at the restrictive temperature (39.5° C) (124). Ts-11 
vaccine administered by eye drop protects chickens against loss of egg production and air sac 
lesions and is nonpathogenic for turkeys (124). 
Bacterins are available to the commercial poultry industry which can be used to 
immunize chickens or turkeys. One or two doses of MG bacterin in white leghorn chickens 
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have been found to protect against drops in egg production and to reduce transmission of M 
gallisepticum via eggs (111). Immunization of turkeys with commercially available MG 
bacterins (7, 61) is possible but two doses are required to develop an effective immunity. 
Since M gallisepticum does not possess a cell wall, membrane proteins interact with 
host immune cells during infection and probably represent the antigens responsible for 
inducing immunity in chickens. Antibodies against protein p64 inhibit growth and 
attachment of MG to chick tracheal rings (13, 54). Future vaccines for control of M. 
gallisepticum in chickens and turkeys may consist of protein subunits, such as p64 or p98, 
(13, 47). However, variable expression of MG surface epitopes must be taken into account 
during production of vaccines and diagnostic antigens (55). 
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MATERIALS AND METHODS 
Experimental Turkeys. Forty eight ( 48) Nicholas Large White male turkeys were 
purchased from a commercial flock and randomly assigned to one of 4 experimental groups 
(Frey's media-inoculated controls, Mycoplasma gallisepticum (R strain)-inoculated, 
Mycop/asma synoviae-inoculated, and Mycoplasma meleagridis-inoculated). Prior to 
inoculation at 46 days of age, each turkey was examined and found to be negative for pre-
existing mycoplasma infections by tracheal culture and serology. Serological testing 
included both the serum plate agglutination and hemagglutination inhibition tests for 
Mycoplasma gallisepticum, Mycoplasma meleagridis (MM), and Mycoplsma synoviae (MS) . 
Tracheal cultures and serological tests were performed at the National Veterinary Services 
Laboratories in Ames, Iowa using protocols established and approved by the National Poultry 
Improvement Plan. Feed and water were provided ad libitum. Turkeys were euthanized by 
intravenous injection of sodium pentobarbital immediately prior to tissue collection. 
Experimental Design. Tissues were collected at 1, 2, 3, and 4 weeks postinoculation 
(PI) as indicated in Table 1. 
Inocula. Mycoplasma gallisepticum, M synoviae, and M meleagridis were propagated 
in Frey's medium for 24 hours at 37 °C to achieve a broth culture containing approximately 
1X108 color change units/ml. Each mycoplasma-inoculated turkey received an injection of 
0.2 ml of infectious broth culture into each infraorbital sinus and 0.25 ml was injected into 
the trachea. Turkeys in the control group received an injection of 0.2 ml of Frey's media 
into each infraorbital sinus and 0.25 ml was injected into the trachea. 
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Table 1. Collection ofrespiratory tissues from turkeys at 1, 2, 3, and 4 weeks following 
inoculation with Frey's media (C), Mycoplasma gallisepticum (MG), Mycoplasma 
meleagridis (MM), or Mycoplsma synoviae (MS). 
Tissue Collection Times at Experimental Groups 
Weeks Postinoculation Control MG MS MM 
1 3* 3 3 3 
2 3 3 3 3 
3 3 3 3 3 
4 3 3 3 3 
Total 12 12 12 12 
* Number of turkeys 
Mycoplasma Isolation and Serology. To ensure that experimental birds became 
infected with the appropriate mycoplasma species and remain free of other mycoplasma, a 
serum sample was taken from each of the 48 experimental turkeys immediately prior to 
euthanasia. Each serum sample was tested for antibodies against MG, MS, and MM by the 
serum plate agglutination (SP A) and hemagglutination inhibition (HI) tests (97). Also, 
tracheas were collected from each turkey at necropsy and cultured in Frey's media. 
Tissue Collection, Fixation, and Scoring. Respiratory tissues collected from each of 
the 48 experimental turkeys include the outer wall of the left and right infraorbital sinus, left 
and right lung, and tissue from the upper third and lower third of the trachea. Two different 
fixatives, 10% neutral buffered formalin and methyl pentanedial glycol (Excell, American 
Histology Reagent Company, Lodi, California 95241), were used to fix each tissue. Each 
tissue from each turkey was subdivided into four portions. One portion of each tissue was 
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fixed for 6 hours in 10% buffered formalin, one portion was fixed for 6 hours in methyl 
pentanedial glycol, one portion was fixed for 24 hours in 10% buffered formalin, and the 
remaining portion was fixed for 24 hours in methyl pentanedial glycol. Following fixation, 
tissues were transferred into 70% ethyl alcohol, processed, and embedded in paraffin within 
48 hours. The intensity of staining was semiquantitatively measured by assigning a 
numerical staining score. Staining scores ranged from 0 to 3; 0 = no staining, 1 = mild 
staining with less than 30% of the cell population stained, 2 =moderate staining with less 
than 60% of the cell population stained, and 3 =strong staining with the majority of the cells 
stained. 
Avidin-Biotin Immunoperoxidase Procedure. Sections 3µm thick were mounted on 3-
aminopropyl-triethoxy-silane glass slides, dehydrated and deparaffinized in 2 changes (5 
minutes each) of xylene and rehydrated through graded alcohol baths to ultrapure water. 
Antigen retrieval was accomplished by microwaving tissues in citrate buffer at pH 6.0 for 2.5 
minutes at 800 watts followed by 10 minutes at 180 watts. Slides were cooled for 20 minutes 
in a freezer at -20°C, washed in phosphate buffered saline, and placed on slide racks in a 
humidified chamber. Avidin blocking (Zymed Laboratories, South San Francisco, CA) for 
15 minutes was followed by washing in buffer, 15 minutes of biotin blocking (Zymed 
Laboratories, South San Francisco, CA), and another wash in the buffer solution. Tissues on 
each slides were incubated in 300 µl of 20% normal goat serum (Sigma Chemical Co., St. 
Louis, MO) for 15 minutes at room temperature and then washed in buffer. Next, tissues 
were exposed to 300µ1 of pooled primary rabbit anti-MG antibody (National Veterinary 
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Services Laboratories, Ames, Iowa) diluted 1 :5000 with reagent diluent (BioGenex, San 
Ramon, CA) for 16 hours at 4 ° C in a humidified chamber. Each slide was washed three 
times in phosphate buffered saline. To inactivate endogenous peroxidase, specimens were 
subjected to three sequential 15 minute treatments with 300 µ13% hydrogen peroxide (Fisher 
Scientific, Itasca, 11) with a buffer wash between each treatment and 3 buffer washes after the 
final exposure to hydrogen peroxide. Three hundred microliters ofbiotinylated goat anti-
rabbit immunoglobulins (Vector Laboratories, Burlington, CA) diluted 1 :200 with reagent 
diluent was applied to each slide for 15 minutes at room temperature. Three buffer washes 
was followed by a 15 minute exposure at room temperature to horse radish peroxidase 
labeled steptavidin (Zymed Laboratories, South San Francisco, CA) diluted 1 :200. After an 
additional 3 washes in buffer, sections were allowed to react with 300 µl of freshly made 3-
amino-9-ethylcarbazole (The New Polyscience, Warrington, PA) for 15 minutes at room 
temperature. Each tissue was washed 3 times in buffer. Slides were reassembled on a rack, 
counterstained for 60 seconds with 1/4 strength instant hematoxylin (Shandon, Pittsburgh, 
PA), washed 3 times in ultrapure water, and placed for 30 seconds in Scott's tap water. Next, 
300 µl of SuperMount (BioGenex, San Ramon, CA) was applied to each slide and slides 
were placed in an oven at 58 °C for 1 hour. Finally, 150 µl ofRefrax Mounting Medium 
(BioGenex, San Ramon, CA) was placed on each slide and slides were coverslipped. 
Statistics. An analysis of variance (ANOVA) method, with the block effect of different 
weeks, provided an F test of the null hypothesis that the population means for different levels 
of each variable are identical. Variables tested consisted of treatment (Frey's media-
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inoculated controls, Mycoplasma gallisepticum (R strain)-inoculated, Mycoplasma synoviae-
inoculated, or Mycoplasma meleagridis-inoculated), fixative (10% neutral buffered formalin 
or methyl pentanedial glycol), fixation time (6 hours or 24 hours), and type of tissue 
(infraorbital sinus, trachea, or lung). The significance level used was 0.05 (110). 
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RESULTS 
Clinical Signs and Macroscopic Lesions. By two weeks postinoculation, M 
gallisepticum-inoculated turkeys began showing clinical signs of coughing and infraorbital 
sinus swelling. Gelatinous exudate was present both in the left and right infraorbital sinuses 
of the MG inoculated turkeys 2 weeks postinoculation and air sac had a light cloudiness. No 
clinical signs or macroscopic lesions were seen in the control, MM, or MS groups. 
Mycoplasma Isolation. M gallisepticum was re-isolated from tracheas of 100% of the 
turkeys inoculated with MG (Table 2). All turkeys inoculated with MS were culture-positive 
for M synoviae except for one individual necropsied at 7 days postinoculation (Table 3). 
Mycoplasma meleagridis was not re-isolated from any turkeys inoculated with MM culture 
broth (Table 4). 
Serology. All turkeys in the M gallisepticum group were positive by the serum plate 
agglutination test (SP A). Antibody titers measured by the hemagglutination inhibition (HI) 
test ranged from 1 :20 to 1 :80 and were detected in all turkeys except for one bird necropsied 
at 7 days post inoculation (Table 2). In the M synoviae group, no antibody response was 
detected at 1 week post inoculation. Thereafter, the humoral antibody response varied 
between turkeys, between weeks, and between serological tests. Hemagglutination-inhibition 
antibody titers were lower in MS turkeys than in turkeys inoculated with M gal/isepticum 
(Table 3). Mycoplasma meleagridis-inoculated turkeys showed inconsistent antibody 
responses with variability similar to that observed in the M synoviae group (Table 4). 
Avidin-biotin Immunoperoxidase Test. Results applying the avidin-biotin 
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immunoperoxidase test to tissues from turkeys infected with M gallisepticum are shown in 
Table 5. The intensity of staining was semiquantitatively measured by assigning a numerical 
staining scores that ranged from 0 to 3 (Fig. 1, 2, 3, and 4). In most instances, staining of M 
gallisepticum antigen was significantly more intense on infraorbital sinus epithelium than on 
respiratory epithelium from the trachea or lung (P(0.05; Table 5). Sinus mucosa from all six 
turkeys necropsied at the first week or fourth week postinoculation were positive by avidin-
biotin immunoperoxidase staining. Tracheas showed variable results from negative (0) to 
strong (3) staining. One lung from one turkey at one week postinoculation and one lung 
from one turkey at three weeks postinoculation showed moderate staining on the epithelium 
adjacent to primary bronchi. Both of these lungs were fixed in 10% neutral buffered 
formalin. 
When data from formalin and methyl pentanedial glycol fixation were analyzed by 
ANOV A, it was determined that the six hour fixation time offers better antigen preservation 
than 24 hours in a fixative (P(0.05). Statistical analysis indicated no difference in antigen 
staining between tissues fixed in methyl pentanedial glycol and tissues fixed in 10% neutral 
buffered formalin. 
There was a difference in staining intensity between weeks in turkeys inoculated with 
Mycoplasma gallisepticum. The intensity of M gallisepticum antigen staining on infraorbital 
sinus epithelium was greatest at the first and fourth weeks postinfection (Table 5). All 
turkeys tested at these times showed some degree of positive staining. In contrast, sinus 
tissues collected at the second and third week postinoculation showed variable results that 
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ranged from negative (0) to moderate (2) staining. 
The specificity of the avidin-biotin immunoperoxidase test was not complete. The 
intensity of staining was significantly greater in tissues from turkeys inoculated with M 
gallisepticum (P(0.05). None of the tissues from the M meleagridis and control groups were 
stained. However, some staining was observed for M gallisepticum antigen in the ciliated 
brush border of tracheal epithelial cells from turkeys inoculated with M synoviae. No 
staining was detected on sinus epithelium from turkeys infected with M synoviae. 
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Table 2. Serum plate agglutination reactions, hemagglutination inhibition 
titers, and reisolations at 1, 2, 3, and 4 weeks following inoculation of 
turkeys with Mycoplasma gallisepticum. 
Weeks Turkey Serum Plate Hemagglutination Culture 
Postinoculation Number Agglutination Inhibition 
1 1 + + 
2 + 1:20 + 
3 + 1:20 + 
2 4 + 1:80 + 
5 + 1:20 + 
6 + 1:40 + 
3 7 + 1:80 + 
8 + 1:80 + 
9 + 1:80 + 
4 10 + 1:80 + 
11 + 1:80 + 
12 + 1:40 + 
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Table 3. Serum plate agglutination reactions, hemagglutination inhibition 
titers, and reisolations at 1, 2, 3, and 4 weeks following inoculation of turkeys 
with Mycoplasma synoviae. 
Weeks Turkey Serum Plate Hemagglutination Culture 
Postinoculation Number Agglutination Inhibition 
1 1 
2 + 
3 + 
2 4 + 1:20 + 
5 + 1:20 + 
6 + + 
3 7 + 1:20 + 
8 + 
9 + 
4 10 + + 
11 + 1:20 + 
12 + 1:40 + 
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Table 4. Serum plate agglutination reactions, hemagglutination inhibition titers, and 
reisolations at 1, 2, 3, and 4 weeks following inoculation of turkeys with Mycoplasma 
meleagridis. 
Weeks Turkey 
Postinoculation Number 
1 1 
2 
3 
2 4 
5 
6 
3 7 
8 
9 
4 10 
11 
12 
Serum Plate 
Agglutination 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Hemagglutination 
Inhibition 
1:40 
1:40 
1:20 
1:20 
1:20 
1:20 
Culture 
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Table 5. Avidin-biotin immunoperoxidase staining for mycoplasma gallisepticum in 
turkey sinus, trachea, and lung at 1, 2, 3, & 4 weeks postinoculation following 
fixation in methyl pentanedial glycol (MPG) or formalin for 6 hours or 24 hours. 
Weeks Postinoculation Fixative-Time (hours) Sinus Trachea Lung 
1 MPG-6 2.8#* 2.2 0.0 
MPG-24 3.0* 2.2 0.0 
Formalin-6 2.0* 1.8 0.7 
Formalin-24 1.5* 2.2 0.3 
2 MPG-6 0.8 1.0 0.0 
MPG-24 0.0 0.0 0.0 
Formalin-6 0.5 0.7 0.0 
Formalin-24 0.5* 0.7 0.0 
3 MPG-6 1.7* 2.0 0.0 
MPG-24 0.0 0.7 0.0 
Formalin-6 0.8 1.0 0.3 
Formalin-24 0.5 0.7 0.0 
4 MPG-6 2.8* 0.7 0.0 
MPG-24 1.5* 0.7 0.0 
Formalin-6 2.0* 0.3 0.0 
Formalin-24 1.5* 0.2 0.0 
# Mean staining scores from two observations on the sinus, lung, or trachea from each of 3 
turkeys (n=6). 
*Values within a row are significantly different (P(0.05). 
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Table 6. Avidin-biotin immunoperoxidase staining for mycoplasma gallisepticum antigen 
on turkey sinus epithelium at 1, 2, 3, & 4 weeks postinoculation following 6 hours or 24 
hours of fixation. 
Weeks Fixation Time 
Postinoculation 6 hours 24 hours 
1 2.40* 2.33 
2 0.67 0.00 
3 1.25 0.27 
4 2.36 1.50 
* Mean staining scores of four observations from each of 3 turkeys on sinus epithelium fixed 
in formalin or methyl pentanedial glycol (n=12). 
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Fig. 1. Normal epithelium covering the mucosal surface of the infraorbital sinus from a 
turkey inoculated with Frey's media. No staining is present on the apical surface of 
respiratory epithelial cells which results in a staining score of 0. Magnification= 160X. 
Fig. 2. Weak avidin-biotin immunoperoxidase staining of M gallisepticum antigen in the 
ciliated brush border of infraorbital sinus surface epithelial cells is characteristic of 
tissues assigned a staining score of 1. Red-brown stain deposits are small and widely 
separated. Magnification = 160X. 
40 
• 
• 
, 
41 
Fig. 3. Moderate avidin-biotin immunoperoxidase staining of M gallisepticum antigen in 
the ciliated brush border of infraorbital sinus epithelial cells is representative of tissues 
assigned a staining score of 2. Red-brown stain deposits are of moderate size and nearly 
contiguous. Magnification = 160X. 
Fig 4. Strong avidin-biotin immunoperoxidase staining of M gallisepticum antigen in the 
ciliated brush border of infraorbital sinus epithelial cells is typical of tissues assigned a 
staining score of 3. Red-brown stain deposits are abundant, large, and contiguous. 
Magnification = 160X. 
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DISCUSSION 
Polyclonal antibodies directed against M gallisepticum were not as specific as desirable 
in a test intended to differentiate between common mycoplasma pathogens of turkeys. The 
use of polyclonal primary antibodies for immunoperoxidase staining of Mycoplasma 
gallisepticum antigens in histology sections is inexpensive, relatively fast, and easy to 
conduct. In addition, polyclonal antibodies will recognize more epitopes than a monoclonal 
antibody preparation. However, in the current study, a low level staining reaction was 
initiated by interaction between MG primary antibodies and M synoviae on epithelial 
surfaces of the trachea but not on epithelial cells of the infraorbital sinus. It is possible that 
M synoviae colonization is heavier in the trachea than in the infraorbital sinus. Cross 
reactivity between M gallisepticum antigen and M. synoviae antibodies has been reported 
with ELISA testing (99). Bradley showed that 53 kDa and 88 kDa MS polypeptides cross 
reacted with MG antisera and a 70 kDa MG polypeptide cross reacted with MS antisera (25). 
In addition, M gallisepticum and M synoviae share 44 kDa and 36 kDa epitopes which react 
to antisera against MG and antisera against MS (2). M gallisepticum and M synoviae 
possess common antigenic determinants which are encoded in the genome of both organisms 
(134). 
In:fraorbital sinuses were the preferred site for M gallisepticum colonization within the 
turkey respiratory tract. Infraorbital sinuses from all MG-inoculated turkeys showed positive 
staining by the avidin-biotin procedure. Furthermore, intensity of staining was significantly 
greater in the infraorbital sinuses than in the trachea or lungs. This finding is consistent with 
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previous reports that lesions of Mycoplasma gallisepticum may be restricted to the swelling 
of the infraorbital sinuses (127). The micro-environment within the sinuses apparently 
provide an ideal environment colonization by M gallisepticum. The apical surface of 
infraorbital sinus epithelium would appear to be the preferred site for utilization of diagnostic 
procedures designed to demonstrate MG antigens or genetic material in infected turkeys. 
Fixation for 6 hours in either formalin or methyl pentanedial glycol resulted in more 
intense avidin-biotin staining for M gallisepticum than fixation for 24 hours. Morphology of 
respiratory epithelial cells on mucosal surfaces was well preserved following 6 hours in 
either fixative. Optimal preservation of antigens in tissue sections requires that the duration 
of fixation be limited to the minimum time required to preserve tissue morphology. Time 
required for complete fixation depends on the rate of fixative penetration and the action of the 
fixative. Fixation activity by formalin progressively improves after a tissue has been 
completely penetrated (66). Approximately one half of formaldehyde uptake by tissue occurs 
in 8 hours but fixation may not be completed until 7 days (29). The rate of penetration and 
mechanism of action of methyl pentanedial glycol is not known. 
Three modifications to the standard avidin-biotin immunoperoxidase procedure were 
necessary to successfully stain M gallisepticum adhering to epithelial cells in the respiratory 
tract of turkeys. Non-specific staining associated with mucus glands was observed in both 
the tracheal and infraorbital sinuses. Use of avidin-biotin blockers successfully removed the 
non-specific staining from the mucosal surfaces of the respiratory tract. This finding is 
consistent with Cauli' s observation of endogenous avidin binding activity in ducts of human 
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salivary glands (30). Endogenous peroxidase activity was suppressed by use of hydrogen 
peroxide at three different steps in the procedure. Erythrocytes contain pseudoperoxidase and 
myeloperoxidase is present in granulocytes ( 46). In avian species, eosinophils have 
peroxidase activity but heterophils do not (9, 91). Antigen retrieval by microwave heating of 
tissue sections increased the intensity of M gallisepticum antigen staining in turkey 
respiratory tissues fixed in formalin or in methyl pentanedial glycol. Microwave heating is 
believed to disrupt cross-linking of proteins caused by tissue fixatives and, in some tissues, 
may eliminate the need for pre-digestion by protease enzymes (114). 
Mycoplasma gallisepticum and M synoviae were readily reisolated from the tracheas of 
inoculated turkeys. This was not the case with Mycoplasma meleagridis which was not 
reisolated from any of the inoculated turkeys. Many isolates of M meleagridis grow poorly 
or not at all in broth ( 48, 130). However, antibodies against MM were detected by both the 
serum plate agglutination test and the hemagglutination-inhibition test at 7, 21, and 28 days 
postinoculation indicating that infection did occur. 
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CONCLUSION 
An avidin-biotin immunoperoxidase diagnostic test was developed to facilitate rapid 
identification of Mycoplasma gallisepticum in respiratory tissues of turkeys. This procedure 
used polyclonal primary antibodies produced in rabbits. Forty eight turkeys were randomly 
assigned to one of four experimental groups of turkeys and inoculated into the infraorbital 
sinus and trachea with the R strain of Mycoplasma gallisepticum, Mycoplasma synoviae, 
Mycoplasma meleagridis, or Frey's media. The outer wall of the infraorbital sinuses, lungs, 
and tracheas were collected and fixed in either 10% neutral formalin or pentanedial methyl 
glycol at 1, 2, 3, 4 weeks postinoculation. Tissues were subdivided and remained in each 
fixative for 6 or 24 hours. 
The avidin-biotin immunoperoxidase diagnostic test was sufficiently sensitive to detect 
M gallisepticum antigen at 1, 2, 3, 4 weeks postinoculation. Staining of M gallisepticum 
was significantly more intense on infraorbital sinus epithelium than on respiratory epithelium 
from the trachea or lung. Statistical analysis indicates that the six hour fixation time offers 
better antigen preservation than 24 hours in a fixative. There was no difference in intensity 
of M. gallisepticum antigen staining in tissues fixed in methyl pentanedial glycol when 
compared to tissues fixed in 10% neutral buffered formalin. Significant differences in 
staining intensity were observed between weeks. 
Specificity of the avidin-biotin immunoperoxidase test was not complete. None of the 
tissues from the M meleagridis and control groups showed staining. No staining was 
observed in the ciliated brush border of infraorbital sinus epithelial cells from turkeys 
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infected with Mycoplasma synoviae. However, weak to moderate staining was observed in 
several tracheas of turkeys inoculated with M. synoviae. Improved specificity of an avidin-
biotin immunoperoxidase diagnostic test to detect M gallisepticum in respiratory tissues of 
turkeys probably will require the use of monoclonal antibodies directed against a specific 
epitope in the cell membrane of Mycoplasma gallisepticum. 
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APPENDIX A: FREY'S MEDIUM FOR AVIAN MYCOPLASMA ISOLATION 
Mycoplasma broth base 
Dextrose 
Swine serum 
Cysteine hydrochloride 
Nicotinamide adenine dinucleotide (NAD) 
Phenol red (1 %) 
Thallium acetate (10%) 
Penicillin G potassium 
Distilled water 
Adjust pH to 7.8 with 20% NaOH, and filter-sterilize 
22.5 g 
3.00 g 
120.0 ml 
0.1 g 
0.1 g 
2.5 ml 
5.0ml 
1,000,000 units 
SQ 1000.0 ml 
Kleven, S. H., and H. Y. Yoder, Jr. Mycoplasmosis. In: A laboratory manual for the 
isolation and identification of avian pathogens. H. G. Purchase, L. H. Arp, C. H. Domermuth, 
and J.E. Pearson, eds. 3rd ed. American Association of Avian Pathologists. Rennett Square, 
Pennsylvania. pp. 57-62. 1989. 
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APPENDIX B: IMMUNOHISTOCHEMISTRY SOLUTIONS 
1. OptiMax Wash Buffer (20X) (500ml) 
500 ml 20X concentrated phosphate buffer saline at pH 7.4± 0.2 with surfactant 
10 L deionized water 
Label, date, initial, and refrigerate at 4 °C 
2. Concentrated Reagent Diluent (reagent diluent)(lOOml) 
Phosphate buffer saline at pH 7 .6 
1% 
0.1 % 
0.09% 
Bovine Serum Albumin 
Tween-20 
Sodium azide 
Stable for 18 months at 2-8 °C 
3. 3% Hydrogen peroxide 
10 ml 30% H20 2 
90 ml ultrapure water 
4. Sodium Acetate Buffer (good for 6 months) 
210 ml O.lON Acetic acid (5 .75 ml GAA/lL H20) 
790ml O.lOM Sodium acetate.3H20 (13.61 g/ 
5. Working ABC (3-amino-9-ethylcarbazole) (make fresh) (filter with plunger) 
2 ml Sodium acetate buffer 
3 drops 
3 drops 
AEC 
1 % hydrogen peroxide 
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